Innophos (NASDAQ:IPHS)

dhabluetzel (98.08) Submitted: 2/22/2008 5:24:33 PM : Start Price: $12.16 IPHS Score: +296.53

I love a dividend yield of 6%

38usc (49.62) Submitted: 2/8/2008 4:57:16 PM : Start Price: $11.34 IPHS Score: +323.47

they do what??

MFPukitoDinero (61.54) Submitted: 12/10/2007 10:14:32 PM : Start Price: $12.95 IPHS Score: -282.88

Bill Mann is wrong on this one!!!

melkore (< 20) Submitted: 11/21/2007 12:24:41 PM : Start Price: $11.75 IPHS Score: +314.89

Growing business trading at an 18% FCF yield. Should be a double over next year.

tenmiles (99.97) Submitted: 8/6/2007 11:03:27 AM : Start Price: $10.76 IPHS Score: -352.85

Sell reflex rally in IPHS; dividend will provide some support but likely buying opportunity 10-20% lower soon

NetscribeBasMtrl (31.14) Submitted: 3/23/2007 8:35:39 AM : Start Price: $14.79 IPHS Score: -229.97

Innophos Holdings is a producer of specialty phosphate salts, acids and related products in the United States, Canada and Mexico. It has three principal product lines: specialty salts and specialty acids, purified phosphoric acid, and technical sodium tripolyphosphates (STPP) and other products. Innophos sells products in end markets that exhibit steady demand growth through economic cycles. Its customer base comprises consumer goods manufacturers and distributors. The customers include consumer goods manufactures in the food, bakery, beverage, pharmaceutical and cleaning product markets.

The North American specialty phosphates market generates approximately 20% of the overall phosphate market. Here, Specialty Salts and Specialty Acids represent 49%, Purified Phosphoric Acid 28% and STPP 23% of the total North American specialty phosphates market. In terms of volume basis, overall specialty phosphate demand has grown about 2% per annum over the last five years. Inspite of the positive opportunities for the company, it is witnessing flattish revenue over last five years. It was more evident with just 1% revenue growth in fiscal year 2006, which was owing to an increase in selling prices of the products of the company.

Recently on 2nd November 2006, company raised an IPO with net proceeds of approximately $86.3 million. They used $83.3 million of the net proceeds from the offering to redeem the principal amount of company’ floating-rate senior notes. For fiscal year 2006, they had a net loss totaled $32.8 million, up from $11.7 million. Higher loss reflects higher interest expense due to expenses related to initial public offering and increased deferred financing cost. Considering the above factors and the deteriorating financials, company seems to be losing the investors’ confidence.